[1]
Alexandru Calin Grigorescu, “Tirosine Kinase Inhibitors (TKI) Used in the Treatment of Non-Small Cell Lung Cancer (NSCLC) Based on Specific Genetic Alterations”, MSTI-V4, pp. 86–93, Feb. 2025.